Chinese medicine in US: The regulatory perspective

Gerald K. Shiu

doi:10.1007/BF02935388

Your Location：

Home >

Browse articles >

Chinese medicine in US: The regulatory perspective

OriginalPaper | Updated：2021-08-27

- Chinese medicine in US: The regulatory perspective
- Chinese medicine in US: The regulatory perspective
- 中国结合医学杂志（英文版） 1997年3卷第2期页码：156
- Affiliations：
  
  American Chinese Pharmaceutical Association,China
- Author bio：
- Funds：
- DOI：10.1007/BF02935388
  中图分类号：
- 纸质出版日期：1997，
Scan for full text
Shiu, G.K. Chinese medicine in US: The regulatory perspective., CJIM 3, 156 (1997). https://doi.org/10.1007/BF02935388

Gerald K. Shiu. Chinese medicine in US: The regulatory perspective[J]. Chinese Journal of Integrative Medicine, 1997,3(2):156.
Shiu, G.K. Chinese medicine in US: The regulatory perspective., CJIM 3, 156 (1997). https://doi.org/10.1007/BF02935388 DOI：

Gerald K. Shiu. Chinese medicine in US: The regulatory perspective[J]. Chinese Journal of Integrative Medicine, 1997,3(2):156. DOI： 10.1007/BF02935388.

摘要

Abstract

关键词

Chinese MedicineDietary SupplementHerbal ProductRegulatory PerspectiveProval

Keywords

Chinese MedicineDietary SupplementHerbal ProductRegulatory PerspectiveProval

references

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

The importance of scientific research on Fu-Fang Chinese medicine prescriptionsChinese medicine prescriptions

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats